Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2024 Filed Oct 2, 2024 18:15 UTC Amendment |
Barber DanielPresident and CEO
|
Tax withholdingCommon Stock | 56,824 | $4.88 | $277,301.12 |
DisclosureSEC source: 0001214659-24-017009 · marketforms-67097.xml · nonDerivative · entry 1 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826,478 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 . Read SEC document |
| March 09, 2024 Filed Oct 2, 2024 18:14 UTC Amendment |
Jung CassieSVP, Operations
|
Tax withholdingCommon Stock | 14,120 | $4.88 | $68,905.60 |
DisclosureSEC source: 0001214659-24-017008 · marketforms-67098.xml · nonDerivative · entry 3 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,066 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 . Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 13:45 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
SaleCommon Stock | 25,000 | $5.19 | $129,685.00 |
DisclosureSEC source: 0001214659-24-004389 · marketforms-65141.xml · nonDerivative · entry 1 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,040,371 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 10:36 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 41,250 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004307 · marketforms-64693.xml · derivative · entry 2 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 41,250 shares Expires 2034-03-07 F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 10:36 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004307 · marketforms-64693.xml · nonDerivative · entry 1 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,065,371 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:36 UTC |
TOTH A ERNEST JRSVP, Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004308 · marketforms-64694.xml · derivative · entry 2 TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-07 F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:36 UTC |
TOTH A ERNEST JRSVP, Chief Financial Officer
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004308 · marketforms-64694.xml · nonDerivative · entry 1 TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:36 UTC |
BRAENDER LORI JSVP, General Counsel
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 67,500 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004309 · marketforms-64690.xml · derivative · entry 2 BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2034-03-07 F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:36 UTC |
BRAENDER LORI JSVP, General Counsel
|
GrantCommon Stock | 135,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004309 · marketforms-64690.xml · nonDerivative · entry 1 BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,761 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Kraus Carl NChief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 56,250 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004306 · marketforms-64692.xml · derivative · entry 2 Kraus Carl N · CIK 0001946475 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2034-03-07 F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Kraus Carl NChief Medical Officer
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004306 · marketforms-64692.xml · nonDerivative · entry 1 Kraus Carl N · CIK 0001946475 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,500 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Barber DanielPresident and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 363,900 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004305 · marketforms-64682.xml · derivative · entry 2 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,900 Underlying: Common Stock · 363,900 shares Expires 2034-03-07 F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Barber DanielPresident and CEO
|
GrantCommon Stock | 242,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004305 · marketforms-64682.xml · nonDerivative · entry 1 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,302 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Jung CassieSVP, Operations
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,625 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004304 · marketforms-65134.xml · derivative · entry 5 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,625 Underlying: Common Stock · 50,625 shares Expires 2024-03-07 F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Jung CassieSVP, Operations
|
GrantCommon Stock | 101,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004304 · marketforms-65134.xml · nonDerivative · entry 4 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,186 F3 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Boyd Peter E.See Remark
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 43,125 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004303 · marketforms-64689.xml · derivative · entry 2 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,125 Underlying: Common Stock · 43,125 shares Expires 2034-03-07 F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:35 UTC |
Boyd Peter E.See Remark
|
GrantCommon Stock | 86,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004303 · marketforms-64689.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,998 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. F2 · balance_after: The original Form 4, filed on 3/9/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares for 59,532 shares owned when in fact 59,748 shares of the Issuer's common stock were owned. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 216 shares. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:34 UTC |
Wargacki StephenSVP, Research & Development
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 56,250 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001214659-24-004302 · marketforms-64695.xml · derivative · entry 3 Wargacki Stephen · CIK 0001960165 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2034-03-07 F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 14:34 UTC |
Wargacki StephenSVP, Research & Development
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004302 · marketforms-64695.xml · nonDerivative · entry 2 Wargacki Stephen · CIK 0001960165 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,919 F3 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 16:30 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
GrantPerformance Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010922 · marketforms-61881.xml · derivative · entry 1 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
TOTH A ERNEST JRSVP, Chief Financial Officer
|
GrantPerformance Stock Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010923 · marketforms-61879.xml · derivative · entry 1 TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
BRAENDER LORI JSVP, General Counsel
|
GrantPerformance Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010927 · marketforms-61884.xml · derivative · entry 1 BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Barber DanielPresident and CEO
|
GrantPerformance Stock Units · Derivative | 223,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010926 · marketforms-61886.xml · derivative · entry 1 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,500 Underlying: Common Stock · 223,500 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Boyd Peter E.See Remark
|
GrantPerformance Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010925 · marketforms-61885.xml · derivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Marshall Ken W.SVP, Chief Commercial Officer
|
GrantPerformance Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010921 · marketforms-61882.xml · derivative · entry 1 Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Kraus Carl NChief Medical Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010919 · marketforms-62126.xml · nonDerivative · entry 1 Kraus Carl N · CIK 0001946475 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Wargacki StephenSVP, Research & Development
|
GrantPerformance Stock Units · Derivative | 67,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010924 · marketforms-61880.xml · derivative · entry 1 Wargacki Stephen · CIK 0001960165 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC |
Jung CassieSVP, Operations
|
GrantPerformance Stock Units · Derivative | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010920 · marketforms-61883.xml · derivative · entry 1 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 12:26 UTC |
COSTA SANTO JDirector
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008794 · marketforms-61960.xml · derivative · entry 2 COSTA SANTO J · CIK 0001013419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Costa's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 16:28 UTC |
Krop JulieDirector
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008797 · marketforms-61961.xml · derivative · entry 1 Krop Julie · CIK 0001643127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 12:26 UTC |
Taglietti MarcoDirector
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008795 · marketforms-61962.xml · derivative · entry 1 Taglietti Marco · CIK 0001408870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 16:24 UTC |
Cochran JohnDirector
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008793 · marketforms-61959.xml · derivative · entry 2 Cochran John · CIK 0001406773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 12:27 UTC |
MORRIS TIMOTHY EDirector
|
GrantStock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008796 · marketforms-61963.xml · derivative · entry 1 MORRIS TIMOTHY E · CIK 0001191286 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 13:41 UTC |
BROWN GREGORY BDirector
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001214659-23-008799 · marketforms-61958.xml · derivative · entry 2 BROWN GREGORY B · CIK 0001373585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| May 05, 2023 Filed May 5, 2023 16:00 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
GrantPerformance Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006558 · marketforms-61240.xml · derivative · entry 1 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
TOTH A ERNEST JRSVP, Chief Financial Officer
|
GrantPerformance Stock Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006559 · marketforms-61241.xml · derivative · entry 1 TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
Wargacki StephenSVP, Research & Development
|
GrantPerformance Stock Units · Derivative | 67,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006560 · marketforms-61242.xml · derivative · entry 1 Wargacki Stephen · CIK 0001960165 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
BRAENDER LORI JSVP, General Counsel
|
GrantPerformance Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006557 · marketforms-61237.xml · derivative · entry 1 BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
Barber DanielPresident and CEO
|
GrantPerformance Stock Units · Derivative | 223,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006556 · marketforms-61227.xml · derivative · entry 1 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,500 Underlying: Common Stock · 223,500 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
Marshall Ken W.SVP, Chief Commercial Officer
|
GrantPerformance Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006553 · marketforms-61239.xml · derivative · entry 1 Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
Jung CassieSVP, Operations
|
GrantPerformance Stock Units · Derivative | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006554 · marketforms-61238.xml · derivative · entry 1 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| May 05, 2023 Filed May 5, 2023 20:00 UTC |
Boyd Peter E.See Remark
|
GrantPerformance Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-006555 · marketforms-61236.xml · derivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-05-05 F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period. Read SEC document |
| March 10, 2023 Filed Mar 11, 2024 14:35 UTC |
Jung CassieSVP, Operations
|
Tax withholdingCommon Stock | 1,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004304 · marketforms-65134.xml · nonDerivative · entry 3 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,936 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. F2 · balance_after: The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,173 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,490 shares reflecting share withheld for the payment of taxes. Read SEC document |
| March 10, 2023 Filed Mar 11, 2024 14:34 UTC |
Wargacki StephenSVP, Research & Development
|
Tax withholdingCommon Stock | 1,981 | $0.79 | $1,572.32 |
DisclosureSEC source: 0001214659-24-004302 · marketforms-64695.xml · nonDerivative · entry 1 Wargacki Stephen · CIK 0001960165 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,419 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. F2 · balance_after: The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,107 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,556 shares reflecting share withheld for the payment of taxes. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 15:07 UTC |
Schobel Alexander MarkChief Innovation/Tech Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003692 · marketforms-59529.xml · nonDerivative · entry 1 Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,871 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 20:05 UTC |
TOTH A ERNEST JRSVP, Chief Financial Officer
|
GrantCommon Stock | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003688 · marketforms-59530.xml · nonDerivative · entry 1 TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 20:07 UTC |
Boyd Peter E.See Remark
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003695 · marketforms-59523.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,532 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 20:07 UTC |
Marshall Ken W.SVP, Chief Commercial Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003694 · marketforms-59527.xml · nonDerivative · entry 1 Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 20:07 UTC |
Jung CassieSVP, Operations
|
GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003693 · marketforms-59531.xml · nonDerivative · entry 1 Jung Cassie · CIK 0001960154 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,747 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 20:06 UTC |
Barber DanielPresident and CEO
|
GrantCommon Stock | 447,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003691 · marketforms-59518.xml · nonDerivative · entry 1 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,702 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.